BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31817606)

  • 1. Pathogenomics of Uterine Fibroids Development.
    Baranov VS; Osinovskaya NS; Yarmolinskaya MI
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtype-Specific Tumor-Associated Fibroblasts Contribute to the Pathogenesis of Uterine Leiomyoma.
    Wu X; Serna VA; Thomas J; Qiang W; Blumenfeld ML; Kurita T
    Cancer Res; 2017 Dec; 77(24):6891-6901. PubMed ID: 29055020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial disparity in uterine leiomyoma: new insights of genetic and environmental burden in myometrial cells.
    Khan NH; McNally R; Kim JJ; Wei JJ
    Mol Hum Reprod; 2024 Feb; 30(3):. PubMed ID: 38290796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic Analysis Identifies Tenascin-C Expression Is Upregulated in Uterine Fibroids.
    Jamaluddin MFB; Nagendra PB; Nahar P; Oldmeadow C; Tanwar PS
    Reprod Sci; 2019 Apr; 26(4):476-486. PubMed ID: 29730954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
    Commandeur AE; Styer AK; Teixeira JM
    Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids.
    Wei T; Geiser AG; Qian HR; Su C; Helvering LM; Kulkarini NH; Shou J; N'Cho M; Bryant HU; Onyia JE
    BMC Womens Health; 2007 Apr; 7():5. PubMed ID: 17407572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular and cytogenetic evidence for the development of fibroids].
    Knapp P; Chabowski A
    Postepy Hig Med Dosw (Online); 2012 Jan; 66():23-32. PubMed ID: 22371402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MED12 and uterine smooth muscle oncogenesis: State of the art and perspectives.
    Croce S; Chibon F
    Eur J Cancer; 2015 Aug; 51(12):1603-10. PubMed ID: 26037152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and Cellular Insights into the Development of Uterine Fibroids.
    Machado-Lopez A; Simón C; Mas A
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic Profiling of Human Uterine Fibroids Reveals Upregulation of the Extracellular Matrix Protein Periostin.
    Jamaluddin MFB; Ko YA; Kumar M; Brown Y; Bajwa P; Nagendra PB; Skerrett-Byrne DA; Hondermarck H; Baker MA; Dun MD; Scott RJ; Nahar P; Tanwar PS
    Endocrinology; 2018 Feb; 159(2):1106-1118. PubMed ID: 29244110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone receptor integrates the effects of mutated MED12 and altered DNA methylation to stimulate RANKL expression and stem cell proliferation in uterine leiomyoma.
    Liu S; Yin P; Kujawa SA; Coon JS; Okeigwe I; Bulun SE
    Oncogene; 2019 Apr; 38(15):2722-2735. PubMed ID: 30538295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From 2646 to 15: differentially regulated microRNAs between progenitors from normal myometrium and leiomyoma.
    Lazzarini R; Caffarini M; Delli Carpini G; Ciavattini A; Di Primio R; Orciani M
    Am J Obstet Gynecol; 2020 Jun; 222(6):596.e1-596.e9. PubMed ID: 31874141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGA2-mediated tumorigenesis through angiogenesis in leiomyoma.
    Li Y; Qiang W; Griffin BB; Gao T; Chakravarti D; Bulun S; Kim JJ; Wei JJ
    Fertil Steril; 2020 Nov; 114(5):1085-1096. PubMed ID: 32868105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficient H2A.Z deposition is associated with genesis of uterine leiomyoma.
    Berta DG; Kuisma H; Välimäki N; Räisänen M; Jäntti M; Pasanen A; Karhu A; Kaukomaa J; Taira A; Cajuso T; Nieminen S; Penttinen RM; Ahonen S; Lehtonen R; Mehine M; Vahteristo P; Jalkanen J; Sahu B; Ravantti J; Mäkinen N; Rajamäki K; Palin K; Taipale J; Heikinheimo O; Bützow R; Kaasinen E; Aaltonen LA
    Nature; 2021 Aug; 596(7872):398-403. PubMed ID: 34349258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas.
    Galindo LJ; Hernández-Beeftink T; Salas A; Jung Y; Reyes R; de Oca FM; Hernández M; Almeida TA
    Gynecol Oncol; 2018 Sep; 150(3):562-568. PubMed ID: 30017537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25-dihydroxyvitamin d3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells.
    Halder SK; Osteen KG; Al-Hendy A
    Biol Reprod; 2013 Dec; 89(6):150. PubMed ID: 24174578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs involved in the HMGA2 deregulation and its co-occurrence with MED12 mutation in uterine leiomyoma.
    Mello JBH; Barros-Filho MC; Abreu FB; Cirilo PDR; Domingues MAC; Pontes A; Rogatto SR
    Mol Hum Reprod; 2018 Nov; 24(11):556-563. PubMed ID: 30376129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MED12 exon 2 mutations in histopathological uterine leiomyoma variants.
    Mäkinen N; Vahteristo P; Kämpjärvi K; Arola J; Bützow R; Aaltonen LA
    Eur J Hum Genet; 2013 Nov; 21(11):1300-3. PubMed ID: 23443020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenomic and enhancer dysregulation in uterine leiomyomas.
    Mlodawska OW; Saini P; Parker JB; Wei JJ; Bulun SE; Simon MA; Chakravarti D
    Hum Reprod Update; 2022 Jun; 28(4):518-547. PubMed ID: 35199155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of HMGA2 in uterine leiomyomas points to its general role for the pathogenesis of the disease.
    Klemke M; Meyer A; Nezhad MH; Bartnitzke S; Drieschner N; Frantzen C; Schmidt EH; Belge G; Bullerdiek J
    Genes Chromosomes Cancer; 2009 Feb; 48(2):171-8. PubMed ID: 18980243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.